A retrospective cohort study assessing the seroresponse over time to SARS-CoV-2 vaccines among maintenance dialysis patients over 6 months
Latest Information Update: 30 Mar 2022
At a glance
- Drugs Ad26.COV2 S (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
Most Recent Events
- 30 Mar 2022 New trial record
- 01 Mar 2022 Results published in the Clinical Journal of The American Society of Nephrology: CJASN